TY - JOUR
T1 - Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
JO - The Lancet
UR - http://eprints.whiterose.ac.uk/169309/
PY - 2020/12/08
AU - Voysey M
AU - Clemens SAC
AU - Madhi SA
AU - Weckx LY
AU - Folegatti PM
AU - Aley PK
AU - Angus B
AU - Baillie VL
AU - Barnabas SL
AU - Bhorat QE
AU - Bibi S et al
ED -
DO - DOI: 10.1016/s0140-6736(20)32661-1
PB - Elsevier BV
VL - 397
IS - 10269
SP - 99
EP - 111
Y2 - 2025/05/23
ER -